Related Experiment Video
Updated: Aug 9, 2026
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Integrated dystrophin analysis using immunocytochemical, biochemical and genetic techniques
L V Nicholson1, M A Johnson, K E Davies
1Muscular Dystrophy Group Research Laboratories, Newcastle General Hospital, Newcastle upon Tyne, U.K.
Insights
Investigating X-linked muscular dystrophy involves combining immunocytochemistry, immunoblotting, and DNA analysis. This approach helps identify the specific defective gene product causing the condition.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Immunocytochemistry is a valuable technique for diagnosing clinical issues.
- Complementary methods like immunoblotting and DNA analysis enhance diagnostic capabilities.
Purpose of the Study:
- To demonstrate the combined use of immunocytochemistry, immunoblotting, and DNA analysis.
- To investigate the defective gene product in X-linked muscular dystrophy.
Main Methods:
- Utilizing immunocytochemistry for protein localization.
- Employing immunoblotting for protein identification and quantification.
- Applying DNA analysis for genetic defect identification.
Main Results:
- The study presents a case example integrating these three techniques.
- The defective gene product in X-linked muscular dystrophy was successfully investigated.
Conclusions:
- The synergistic application of immunocytochemistry, immunoblotting, and DNA analysis is effective for elucidating complex genetic disorders.
- This integrated approach aids in understanding the molecular basis of diseases like X-linked muscular dystrophy.
Abstract:
Immunocytochemistry is a powerful tool for the elucidation of clinical problems, particularly when used in conjunction with complementary techniques such as immunoblotting and DNA analysis. We would like to present an experimental example which illustrates the way these three different disciplines were brought together to investigate the defective gene product in X-linked muscular dystrophy.
